These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32423203)

  • 1. Long-Acting Human Growth Hormone Receptor Antagonists Produced in
    Wang Y; Langley RJ; Tamshen K; Jamieson SM; Lu M; Maynard HD; Perry JK
    Bioconjug Chem; 2020 Jun; 31(6):1651-1660. PubMed ID: 32423203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Code Expansion Enables Site-Specific PEGylation of a Human Growth Hormone Receptor Antagonist through Click Chemistry.
    Tamshen K; Wang Y; Jamieson SMF; Perry JK; Maynard HD
    Bioconjug Chem; 2020 Sep; 31(9):2179-2190. PubMed ID: 32786367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human growth hormone antagonist B2036 does not interact with the prolactin receptor.
    Goffin V; Bernichtein S; Carrière O; Bennett WF; Kopchick JJ; Kelly PA
    Endocrinology; 1999 Aug; 140(8):3853-6. PubMed ID: 10433247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A long-acting, mono-PEGylated human growth hormone analog is a potent stimulator of weight gain and bone growth in hypophysectomized rats.
    Cox GN; Rosendahl MS; Chlipala EA; Smith DJ; Carlson SJ; Doherty DH
    Endocrinology; 2007 Apr; 148(4):1590-7. PubMed ID: 17234711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Bioactivity of a Human GHR Antagonist Generated by Solid-Phase Site-Specific PEGylation.
    Wang Y; Langley RJ; Tamshen K; Harms J; Middleditch MJ; Maynard HD; Jamieson SMF; Perry JK
    Biomacromolecules; 2021 Feb; 22(2):299-308. PubMed ID: 33295758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding and functional studies with the growth hormone receptor antagonist, B2036-PEG (pegvisomant), reveal effects of pegylation and evidence that it binds to a receptor dimer.
    Ross RJ; Leung KC; Maamra M; Bennett W; Doyle N; Waters MJ; Ho KK
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1716-23. PubMed ID: 11297608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prokaryotic soluble overexpression and purification of bioactive human growth hormone by fusion to thioredoxin, maltose binding protein, and protein disulfide isomerase.
    Nguyen MT; Koo BK; Thi Vu TT; Song JA; Chong SH; Jeong B; Ryu HB; Moh SH; Choe H
    PLoS One; 2014; 9(3):e89038. PubMed ID: 24614134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone excess and the development of growth hormone receptor antagonists.
    Higham CE; Trainer PJ
    Exp Physiol; 2008 Nov; 93(11):1157-69. PubMed ID: 18617577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenyl amide linker improves the pharmacokinetics and pharmacodynamics of N-terminally mono-PEGylated human growth hormone.
    Wu L; Ji S; Shen L; Hu T
    Mol Pharm; 2014 Sep; 11(9):3080-9. PubMed ID: 25115329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone (GH) receptor blockade with a PEG-modified GH (B2036-PEG) lowers serum insulin-like growth factor-I but does not acutely stimulate serum GH.
    Thorner MO; Strasburger CJ; Wu Z; Straume M; Bidlingmaier M; Pezzoli SS; Zib K; Scarlett JC; Bennett WF
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2098-103. PubMed ID: 10372717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and function of a dual antagonist of the human growth hormone and prolactin receptors with site-specific PEG conjugates.
    Basu R; Brody R; Sandbhor U; Kulkarni P; Davis E; Swegan D; Caggiano LJ; Brenya E; Neggers S; Kopchick JJ
    J Biol Chem; 2023 Aug; 299(8):105030. PubMed ID: 37442239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegvisomant: structure and function.
    Pradhananga S; Wilkinson I; Ross RJ
    J Mol Endocrinol; 2002 Aug; 29(1):11-4. PubMed ID: 12200225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical and enzymatic site specific PEGylation of hGH.
    da Silva Freitas D; Mero A; Pasut G
    Bioconjug Chem; 2013 Mar; 24(3):456-63. PubMed ID: 23432141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G120K-PEG, a human GH antagonist, decreases GH signal transduction in the liver of mice.
    Thirone AC; Carvalho CR; Saad MJ
    Mol Cell Endocrinol; 2002 Jun; 192(1-2):65-74. PubMed ID: 12088868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Recombinant Methioninase for Cancer Treatment.
    Hoffman RM; Tan Y; Li S; Han Q; Yagi S; Takakura T; Takimoto A; Inagaki K; Kudou D
    Methods Mol Biol; 2019; 1866():107-131. PubMed ID: 30725412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long-acting, highly potent interferon alpha-2 conjugate created using site-specific PEGylation.
    Rosendahl MS; Doherty DH; Smith DJ; Carlson SJ; Chlipala EA; Cox GN
    Bioconjug Chem; 2005; 16(1):200-7. PubMed ID: 15656592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical and Enzymatic Site Specific PEGylation of hGH: The Stability and in vivo Activity of PEG-N-Terminal-hGH and PEG-Gln141-hGH Conjugates.
    Grigoletto A; Mero A; Zanusso I; Schiavon O; Pasut G
    Macromol Biosci; 2016 Jan; 16(1):50-6. PubMed ID: 26350165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of different growth hormone (GH) mutants on the regulation of GH-receptor gene transcription in a human hepatoma cell line.
    Deladoëy J; Gex G; Vuissoz JM; Strasburger CJ; Wajnrajch MP; Mullis PE
    Eur J Endocrinol; 2002 Apr; 146(4):573-81. PubMed ID: 11916628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, development and evaluation of PEGylated rhGH with preserving its bioactivity at highest level after modification.
    Karbasian M; Kouchakzadeh H; Anamaghi PN; Sefidbakht Y
    Int J Pharm; 2019 Feb; 557():9-17. PubMed ID: 30576790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pegvisomant, a growth hormone-specific antagonist, undergoes cellular internalization.
    Maamra M; Kopchick JJ; Strasburger CJ; Ross RJ
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4532-7. PubMed ID: 15356058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.